peptide ghk-cu (50mg) – Nordsci GHK-Cu 50mg | Skin &

It keeps injection volumes small enough for subcutaneous delivery while remaining measurable on an insulin syringe

Stop and reassess Stop the protocol and seek qualified medical care if pronounced symptoms appear: significant swelling, ongoing dizziness, rapid heart rate, shortness of breath, or marked fatigue

Heres what we know from the available data thus far: No reported toxicity in preclinical injection studies No behavioral or pathological abnormalities observed No adverse safety signals in topical skin care studies Theoretical concerns about copper overload exist, but no study to date has demonstrated this outcome with GHK-Cu

C.WagnerD

What kind of results can I expect